NCT07642856Recruiting
Individualized Neuro-Modulation Paired With Cerebellar Therapy
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
The purpose of this project is to evaluate feasibility and preliminary efficacy of pairing personalized transcranial direct current stimulation (tDCS) with individualized rehabilitation therapy in people with cerebellar damage.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 8 Jun 2026
- Start date
- 30 Jun 2026
- Primary completion date
- 2 Jul 2032
- Lead sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Diseases
- Stroke
- NCT number
- NCT07642856
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 30 Jun 2026 to the primary completion date, 2 Jul 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Specific medications: tricyclic anti-depressants or neuroleptic medication
Other illness
- Heart pacemaker or other MRI-incompatible implanted metal device
- Seizures or history of seizure disorder
- Alcohol or substance use disorder (self-report)
- Diagnosed history of severe psychiatric disorder such as depression, schizophrenia (self-report)
- Any medical condition (including orthopedic, pain, cardiopulmonary or other) that limits safe participation in exercise training
Other
- Diagnoses or impairments that interfere with task execution or data interpretation.
- Metallic foreign body in their eye or head
- Experience with severe claustrophobia
- Experience discomfort from the MRI scan, such as excessive heating of tattoos
- Metallic foreign body in their eye or head (except the mouth e.g. dental fillings)
Who the study is looking for
- Age 18-75 years
- Males and Females
- Disorders that predominantly affect the cerebellum: damage from stroke, tumor or degeneration (genetic or non-genetic causes, congenital hypoplasia).
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Motion Analysis Lab in the Kennedy Krieger Institute Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.